These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. HER1/EGFR tyrosine kinase inhibitors for the treatment of glioblastoma multiforme. Raizer JJ J Neurooncol; 2005 Aug; 74(1):77-86. PubMed ID: 16078112 [TBL] [Abstract][Full Text] [Related]
26. The sequential use of carmustine wafers (Gliadel®) and post-operative radiotherapy with concomitant temozolomide followed by adjuvant temozolomide: a clinical review. Dixit S; Hingorani M; Achawal S; Scott I Br J Neurosurg; 2011 Aug; 25(4):459-69. PubMed ID: 21344976 [TBL] [Abstract][Full Text] [Related]
27. Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma. Kim SS; Rait A; Kim E; DeMarco J; Pirollo KF; Chang EH Cancer Lett; 2015 Dec; 369(1):250-8. PubMed ID: 26325605 [TBL] [Abstract][Full Text] [Related]
28. Lipid-Based Nanocarriers in the Treatment of Glioblastoma Multiforme (GBM): Challenges and Opportunities. Gupta T; Sahoo RK; Singh H; Katke S; Chaurasiya A; Gupta U AAPS PharmSciTech; 2023 Apr; 24(4):102. PubMed ID: 37041350 [TBL] [Abstract][Full Text] [Related]
29. Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles. Pistollato F; Bremer-Hoffmann S; Basso G; Cano SS; Elio I; Vergara MM; Giampieri F; Battino M Target Oncol; 2016 Feb; 11(1):1-16. PubMed ID: 26275397 [TBL] [Abstract][Full Text] [Related]
30. Anticancer drug-loaded hydrogels as drug delivery systems for the local treatment of glioblastoma. Bastiancich C; Danhier P; Préat V; Danhier F J Control Release; 2016 Dec; 243():29-42. PubMed ID: 27693428 [TBL] [Abstract][Full Text] [Related]
31. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience. Attenello FJ; Mukherjee D; Datoo G; McGirt MJ; Bohan E; Weingart JD; Olivi A; Quinones-Hinojosa A; Brem H Ann Surg Oncol; 2008 Oct; 15(10):2887-93. PubMed ID: 18636295 [TBL] [Abstract][Full Text] [Related]
33. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment. van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797 [TBL] [Abstract][Full Text] [Related]
34. Herbal Medicine for Glioblastoma: Current and Future Prospects. Khan I; Mahfooz S; Hatiboglu MA Med Chem; 2020; 16(8):1022-1043. PubMed ID: 32000653 [TBL] [Abstract][Full Text] [Related]
35. The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells. Atif F; Patel NR; Yousuf S; Stein DG PLoS One; 2015; 10(6):e0131441. PubMed ID: 26110872 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma. Tian T; Mingyi M; Qiu X; Qiu Y Oncotarget; 2016 Nov; 7(48):79584-79595. PubMed ID: 27792996 [TBL] [Abstract][Full Text] [Related]
37. Progress of studies on natural products for glioblastoma therapy. Xu F; Yang YH; Yang H; Li W; Hao Y; Zhang S; Zhang YZ; Cao WX; Li XX; Du GH; Ji TF; Wang JH J Asian Nat Prod Res; 2024 Jan; 26(1):154-176. PubMed ID: 38321773 [TBL] [Abstract][Full Text] [Related]
38. Bevacizumab in combination with radiotherapy and temozolomide for patients with newly diagnosed glioblastoma multiforme. van Linde ME; Verhoeff JJ; Richel DJ; van Furth WR; Reijneveld JC; Verheul HM; Stalpers LJ Oncologist; 2015 Feb; 20(2):107-8. PubMed ID: 25582142 [TBL] [Abstract][Full Text] [Related]
39. Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment. Ganipineni LP; Danhier F; Préat V J Control Release; 2018 Jul; 281():42-57. PubMed ID: 29753958 [TBL] [Abstract][Full Text] [Related]